Tingting Zhang’s academic interests have always focused on patient care; initially with the completion of a Medical Degree, then a PhD in pharmacoepidemiology in the Faculty of Pharmaceutical Sciences at the University of British Columbia, Canada. Dr. Zhang’s current research is mainly focused on drug safety/effectiveness, adherence, comorbidity and health services utilization in patients with multiple sclerosis. She is currently a co-principle investigator of a project on the safety and adherence of new oral drugs for MS, which is funded by the Multiple Sclerosis Society of Canada between 2015 and 2018. She has extensive experience in pharmacoepidemiology, health claims database, observational studies and statistical analysis. By using population-based clinical and claims data, Dr. Zhang’s research is aimed at providing evidence in a ‘real-world’ setting over extended periods of time.